Speaker
President & Chief Executive Officer, Molecular Targeting Technologies
Chris Pak, President & Chief Executive Officer at Molecular Targeting Technologies, is speaking at 8th Targeted Radiopharmaceuticals Summit Europe 2026 (London, United Kingdom, 1–3 Dec 2026) in the session “Redefining PRRT: Advancing EBTATE Towards a New Standard of Care for Gastroenteropancreatic Neuroendocrine Tumours”.
1–3 Dec 2026London, United Kingdom
Vice President CMC & Project Lead, OncoOne
Executive Director - Translational Research & Core Facilities ,Program Sponsor, Theranostics, UHN
Chief Executive Officer, OranoMed
Senior Expert - Strategic Therapeutic Innovation, Novartis
Director of Research, Brookline Capital Markets
Chief Technology Officer, Nuclide Therapeutics
This profile is built from conference programmes published on kongre.net. It has not been claimed or confirmed by Chris Pak, and it lists only the talks, sessions and presentations named in those programmes.
Is this you? Claim this profile — every request is read by a person before anything is linked.
To ask for a correction or for this profile to be removed, email [email protected].